Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-systemic vasculitic neuropathy.

Michael P Collins1, M Isabel Periquet

  • 1Neurosciences Department, Marshfield Clinic, Marshfield, Wisconsin 54449, USA. collins.michael@marshfieldclinic.org

Current Opinion in Neurology
|September 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Implications of SMARCA4, ARID1A, and Other BAF Mutations in Non-Small Cell Lung Cancer.

Cancer medicine·2025
Same author

Establishment of normal myofiber size distribution in children and young adults.

Journal of neuropathology and experimental neurology·2025
Same author

The Neuropathies of Vasculitis.

Neurologic clinics·2025
Same author

A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Double Outlet Left Ventricle with Intact Ventricular Septum: A Rare Prenatally Diagnosed Case Report.

Fetal diagnosis and therapy·2024
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
Same journal

Functional movement disorders: diagnosis, pathophysiology, and treatment.

Current opinion in neurology·2026
Same journal

Investigational approaches to multiple sclerosis therapy.

Current opinion in neurology·2026
See all related articles

Non-systemic vasculitic neuropathy presents as a painful, asymmetric nerve disorder. Combination therapy offers better outcomes than corticosteroids alone, with a good prognosis despite a high relapse rate.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Non-systemic vasculitic neuropathy is a localized vasculitis affecting nerves and potentially muscles.
  • Diagnostic criteria and patient cohorts vary across studies.
  • Nerve biopsy is essential for diagnosis, excluding systemic involvement.

Purpose of the Study:

  • Review literature on non-systemic vasculitic neuropathy.
  • Highlight recent advancements in understanding the condition.
  • Summarize clinical presentation, diagnosis, pathology, treatment, and prognosis.

Main Methods:

  • Literature review focusing on recent studies.
  • Analysis of clinical characteristics from new patient cohorts.
  • Examination of pathological findings and therapeutic responses.

Related Experiment Videos

Main Results:

  • New cohorts show higher incidence of painful, asymmetric deficits.
  • High relapse rates, but low risk of systemic spread and good neurological outcomes.
  • Combination therapy superior to corticosteroid monotherapy; magnetic resonance angiography shows diagnostic potential.
  • Pathology suggests T-cell-mediated immunopathogenesis involving cytokines and matrix metalloproteinase-9.

Conclusions:

  • Non-systemic vasculitic neuropathy is an organ-specific condition with good prognosis when treated.
  • Distinguishing it from systemic vasculitis is crucial for management.
  • Pathological evidence supports a primary T-cell-driven process.